Content related to Cell Therapy Program Expands
New Faculty Spotlight: Sarah Richman, MD, PhD
August 31, 2021
Sarah Richman, MD, PhD Cancer and Blood Disease Institute Sarah Richman, MD, PhD, investigates the use of chimeric antigen receptor (CAR) T-cell therapy for solid tumors. She and others in the field
Creating a Safe CAR T-Cell Therapy to Fight Solid Tumors in Children
January 22, 2021
Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.
New cGMP Facility to Benefit Patient Care and Research
April 20, 2021
A state-of-the-art cell therapeutics facility will support the translation of novel cell therapy and tissue engineering approaches into clinical testing for a wide range of human diseases.
CHLA Joins CureWorks Collaborative to Accelerate Development of Immunotherapy Treatments for Childhood Cancers
June 18, 2018
Seattle Children’s, with participating members Children’s Hospital Los Angeles, Children’s National Health System and BC Children’s Hospital, has launched CureWorks, an international collaborative of
Could CAR-T Version 2.0 Be on the Horizon?
March 31, 2020
CHLA scientists work toward a new therapy to target resistant leukemia. Their study, recently published in the journal Leukemia, shows that these new CAR-T cells could be the answer to resistant
Five Things Parents Need to Know About CAR T-Cell Therapy for Cancer
September 16, 2020
In 2018, Children’s Hospital Los Angeles was the first hospital in Southern California approved to deliver a new therapy to pediatric patients with acute lymphoblastic leukemia that did not respond to
Team Led by Children’s Hospital Los Angeles Researcher Generates Comprehensive, Developmental Map of Human T-cells
June 17, 2020
LOS ANGELES (Jun. 16, 2020) — Chintan Parekh, MD, of The Saban Research Institute of Children’s Hospital Los Angeles, has led a team of investigators that generated a comprehensive roadmap for how T
Meet Some of our Research Trainees
December 17, 2021
Stephanie Yi-Tsi Chen, MD Stephanie is a research resident and fellow investigating immunotherapy resistance in neuroblastoma. Stephanie’s dream is to become a pediatric surgeon at an academic